Chronic Fatigue & ME/CFS

If you have spent any time looking into chronic fatigue, you have probably noticed that the word "fatigue" is doing a lot of work. It covers a teenager with mononucleosis. It covers someone who has been bedbound for two years after a viral illness. It covers a working adult whose energy never came back the way it was supposed to after a stressful season of life. These are not the same condition, even when they look similar from the outside. And the part of conventional medicine that treats fatigue tends to flatten the differences in a way that leaves people feeling unseen.

What follows is the version I walk through with patients in clinic. The differences between chronic fatigue, myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), and post-viral fatigue. How ME/CFS gets diagnosed and what the cardinal feature is. The EBV reactivation conversation, including the part where conventional and integrative medicine disagree. The post-viral picture, now substantially expanded by long COVID. What we know about mitochondria. The HPA axis (and why "adrenal fatigue" is the wrong frame). And the management strategy that matters more than any supplement: pacing.

Chronic Fatigue Is an Umbrella Term#

The word "fatigue" gets used for several distinct clinical pictures. It helps to keep them straight.

Idiopathic chronic fatigue. Persistent fatigue without a clear cause, not severe enough to meet ME/CFS criteria, and not following a documented viral or infectious trigger. Often resolves with sleep, stress reduction, and basic medical workup (anemia, thyroid, vitamin D, sleep apnea, depression).

Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). A specific, severely disabling neurological condition with defined diagnostic criteria. The cardinal feature is post-exertional malaise, a worsening of symptoms after physical, cognitive, or emotional exertion that can last days or weeks. ME/CFS also involves unrefreshing sleep, cognitive dysfunction, and orthostatic intolerance [1, 2]. The Institute of Medicine review estimates between 836,000 and 2.5 million Americans have ME/CFS, and most go undiagnosed because medical training does not cover it well [2].

Post-viral fatigue syndrome (PVFS). A broader umbrella that covers ME/CFS along with related conditions following viral infection, including long COVID and post-EBV fatigue. There is meaningful overlap; estimates suggest roughly half of patients with post-COVID syndrome meet ME/CFS criteria [3].

Chronic Epstein-Barr virus (EBV) reactivation. A specific clinical pattern where latent EBV is implicated in ongoing fatigue, brain fog, and immune dysregulation. Conventional medicine and integrative medicine disagree about whether and how to diagnose this. More on that below.

These categories overlap and sometimes coexist in the same patient. Treating them well starts with knowing which picture you are looking at.

How ME/CFS Gets Diagnosed#

There is no biomarker for ME/CFS. Diagnosis is clinical, and several sets of criteria are in use [4]. The two that matter in practice are the Institute of Medicine criteria from 2015 (which proposed renaming ME/CFS to Systemic Exertion Intolerance Disease, or SEID) and the International Consensus Criteria from 2011 [1, 2].

The IOM/SEID criteria require:

• A substantial reduction in the ability to engage in pre-illness activities lasting more than 6 months
• Post-exertional malaise (PEM)
• Unrefreshing sleep
• Plus at least one of: cognitive impairment, or orthostatic intolerance

The International Consensus Criteria are more detailed and require post-exertional neuroimmune exhaustion plus symptoms across multiple domains (neurological, immune, energy production, autonomic) [1].

Two clinical points worth emphasizing:

• Post-exertional malaise is the cardinal feature. It is what distinguishes ME/CFS from generic fatigue. PEM means a worsening of symptoms after exertion that can be delayed by 24-72 hours and can last days or weeks. If a patient feels worse the day after exercise (or even the day after a hard cognitive task), and that worsening reliably follows exertion, that pattern matters more than any single test result.
• Other causes of fatigue must be ruled out first. Anemia, low iron, low vitamin D, hypothyroidism, sleep apnea, depression, and autoimmune disease can all produce a similar picture. The workup is not glamorous, and it is not optional.

Once those are cleared and the post-exertional pattern is documented, ME/CFS becomes the working diagnosis.

EBV Reactivation: The Conversation Conventional Medicine Will Not Have#

Most people have been exposed to Epstein-Barr virus. Most people have antibodies. The virus enters latency in B cells and stays there for life. The question is whether, in some people, latent EBV reactivates in a way that drives chronic fatigue, brain fog, and immune dysregulation, and what the diagnostic threshold for "reactivation" should be.

Here is where the disagreement happens. Conventional medicine narrowly defines EBV reactivation as the presence of detectable viral particles in the blood by PCR. Under that definition, very few patients qualify, and elevated antibody titers without a positive PCR are dismissed as "past exposure."

The integrative and naturopathic position is broader. Elevated EBV antibody titers, particularly EBV nuclear antigen IgG (EBNA-IgG), correlate with development of multiple sclerosis and other autoimmune conditions through a mechanism called molecular mimicry. This part is well-established in the literature [5]. Retrospective pharmacology data suggest that immunosuppressive therapies effective in MS, like rituximab, lower EBNA-IgG titers, supporting the idea that B-cell reservoirs of EBV are part of the disease process. Whether or not "reactivation" in the strict PCR sense is happening, something measurable is going on with EBV antibodies in patients who are profoundly fatigued and whose conventional workup is otherwise negative.

In clinic, my approach is:

• Rule out the common, easier-to-treat causes of fatigue first
• If the picture is consistent with chronic EBV (profound fatigue not relieved by sleep, brain fog, poor stress tolerance, waxing and waning over months), run a 4-antibody EBV panel to distinguish past exposure from active immune engagement: VCA IgM, VCA IgG, EBNA IgG, and Early Antigen (EA) IgG
• Treat for chronic EBV when the antibody pattern is suggestive and quality of life is impacted

Treatment in this setting tends to focus on immune modulation rather than direct antivirals, because conventional antivirals are limited and underperform for this picture. Deep gut work and Chinese herbal approaches such as astragalus are my long-term immune tonic of choice for the off times. Antiviral herbs come in faster when reactivation signs appear: a major stressor, a sudden surge of fatigue, an opportunistic infection. The goal is not to "kill" a virus that is already integrated in your B cells. The goal is to keep the immune surveillance system that holds it in check working well.

The Post-Viral Cluster#

Long COVID has done one useful thing for the broader fatigue conversation: it made the post-viral category visible to medicine in a way ME/CFS alone never managed [3, 6]. The pathophysiology proposed for long COVID overlaps substantially with what researchers have suspected about ME/CFS for decades, including persistent viral reservoirs, reactivation of latent pathogens (EBV, HHV-6, herpesviruses), immune dysregulation, autonomic dysfunction, and possible autoimmunity through molecular mimicry [6, 7].

A 2023 study found that COVID-19 infection triggered reactivation of latent adenovirus in the oral mucosa of ME/CFS patients but not healthy controls, suggesting an exhausted antiviral immune response that loses control of multiple latent infections under stress [7]. This is consistent with what clinicians have observed for years: patients with chronic fatigue often get sicker after acute illness, and that "next layer down" of pathogens is part of the picture.

The practical implication is that post-viral fatigue, regardless of which virus triggered it, often shares a common downstream physiology. Mitochondrial dysfunction. Autonomic dysregulation. Cognitive impairment that is not depression. Pacing requirements. The treatment strategies that work for ME/CFS often help long COVID, and the reverse.

Mitochondria and Energy Production#

The most consistent biological finding across ME/CFS research is mitochondrial dysfunction, and the same finding is now showing up in long COVID and other post-viral fatigue syndromes [8, 9]. The energy your cells produce, the energy your brain uses, the energy your immune system needs to mount appropriate responses, all of it depends on mitochondrial function. When mitochondria are not producing ATP efficiently, the body shifts toward less efficient energy pathways and the threshold for symptom exacerbation drops.

A few practical points:

• Coenzyme Q10 supplementation has the most consistent evidence for symptom improvement in post-viral fatigue syndromes. Several trials show benefit for fatigue and pain measures [9]. It is not a cure, and not everyone responds, but the evidence base is the strongest in this category.
• Aerobic exercise increases mitochondrial density in healthy people, which is why "graded exercise therapy" was historically recommended for ME/CFS. The trouble is that ME/CFS patients have post-exertional malaise, and exercise that exceeds their capacity worsens the condition. The current understanding is that pacing within capacity, not pushing past it, is what protects mitochondrial function over time. Graded exercise therapy in the traditional sense has been removed from major guidelines.
• B vitamins, magnesium, and L-carnitine are co-factors in mitochondrial energy production and are often deficient or relatively insufficient in chronic fatigue patients. Repleting them is part of the foundational work, not a cure on its own.

The HPA Axis (and Why "Adrenal Fatigue" Is the Wrong Frame)#

The wellness-internet explanation for chronic fatigue is often "adrenal fatigue." The medical literature does not support that framing. Your adrenals do not get tired, at least not in the colloquial sense. It's a little more nuanced than that. What does get dysregulated, in chronic stress and chronic illness, is the hypothalamic-pituitary-adrenal (HPA) axis: the feedback loop that controls when cortisol gets released, how much, and at what time of day.

Cortisol itself is not the villain it is sometimes made out to be. It is the hormone that gives you energy, regulates your blood sugar, supports your blood pressure, modulates inflammation, and runs your sleep-wake cycle. Cortisol should be high in the morning (this is what wakes you up feeling rested) and low at night (this is what lets melatonin rise and lets you sleep). When that diurnal rhythm flattens or inverts, you get the picture chronic fatigue patients know well: tired in the morning, wired at night, never quite rested.

The most useful first interventions for HPA dysregulation cost nothing:

• Morning full-spectrum light exposure within 30-60 minutes of waking (sun is best, full-spectrum lamp works)
• Genuine darkness in the evening, especially the hour before sleep
• Consistent sleep and wake times, even on weekends
• Eating something with protein within an hour of waking to support cortisol's normal morning rise

Where supplements come in for the HPA axis, they target specific patterns. Phosphatidylserine has the most evidence for blunting elevated evening cortisol. Adaptogenic herbs like ashwagandha, rhodiola, and eleuthero have clinical use in HPA support, with individual response variation. None of these are first-line. Sleep, light, and rhythm come first.

Pacing and the Energy Envelope#

If there is one management strategy that consistently helps people with ME/CFS, post-viral fatigue, and chronic EBV, it is pacing. Pacing is the discipline of staying inside your "energy envelope," the daily capacity you have without triggering post-exertional malaise. Operating inside the envelope protects you from the crashes. Crossing the envelope, even by a little, often costs days of recovery.

The mechanics of pacing in practice:

• Track your activity in 15-30 minute blocks for a week to learn where your envelope sits, not where you wish it sat
• Plan rest periods proactively, not reactively (rest before you crash, not after)
• Treat cognitive and emotional exertion as exertion, since both can trigger PEM as readily as physical activity
• Work in shorter cycles (45 minutes of activity, 15 minutes flat rest) rather than pushing through

This is not glamorous. It is not what patients want to hear when they want their old life back. It is also the single most effective long-term strategy in the evidence base [2, 4]. Pacing protects the trajectory. Pushing past the envelope shortens it.

What Healing Looks Like#

For patients with idiopathic chronic fatigue and good medical workup, full recovery is common with sleep, stress, and nutrient repletion. For ME/CFS, post-viral fatigue, and chronic EBV, the realistic goal is gradual capacity expansion: a wider envelope, fewer crashes, longer windows of stable function. Some patients reach full functional recovery. Many reach a stable baseline with manageable flares. The trajectory tends to be measured in months and seasons, not weeks.

The patients who do best long-term share a few things in common. They learned their envelope and respected it. They built a treatment plan that addressed multiple layers (immune, mitochondrial, HPA, sleep, sometimes EBV). And they treated relapses as information about what is still active underneath, not as failure.

If you want a more structured walk-through of the EBV picture specifically, the EBV Treatment Algorithm is the flowchart I use with patients. For the broader ME/CFS and post-viral fatigue work, much of what I cover lives inside Wayfinder's Well membership where the relevant courses sit alongside MCAS and gut-motility material.

References#

1. Carruthers BM, van de Sande MI, De Meirleir KL, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270(4):327-338. doi:10.1111/j.1365-2796.2011.02428.x
2. Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223-249. doi:10.1515/reveh-2015-0026
3. Grach SL, Seltzer J, Chon TY, Ganesh R. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc. 2023;98(10):1544-1551. doi:10.1016/j.mayocp.2023.07.032
4. Smith MEB, Nelson HD, Haney E, et al. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Evid Rep Technol Assess (Full Rep). 2014;(219):1-433. doi:10.23970/AHRQEPCERTA219
5. Maksoud R, Magawa C, Eaton-Fitch N, Thapaliya K, Marshall-Gradisnik S. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. BMC Med. 2023;21(1):189. doi:10.1186/s12916-023-02893-9
6. Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023;12:e86002. doi:10.7554/eLife.86002
7. Hannestad U, Apostolou E, Sjögren P, et al. Post-COVID sequelae effect in chronic fatigue syndrome: SARS-CoV-2 triggers latent adenovirus in the oral mucosa. Front Med (Lausanne). 2023;10:1208181. doi:10.3389/fmed.2023.1208181
8. Syed AM, Karius AK, Ma J, Wang PY, Hwang PM. Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Physiology (Bethesda). 2025;40(4). doi:10.1152/physiol.00056.2024
9. Mantle D, Hargreaves IP, Domingo JC, Castro-Marrero J. Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview. Int J Mol Sci. 2024;25(1):574. doi:10.3390/ijms25010574